These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37789566)
21. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis. Liu ZJ; Lin HX; Liu GL; Tao QQ; Ni W; Xiao BG; Wu ZY Clin Genet; 2017 Sep; 92(3):267-273. PubMed ID: 28429524 [TBL] [Abstract][Full Text] [Related]
22. The National ALS Registry: a recruitment tool for research. Malek AM; Stickler DE; Antao VC; Horton DK Muscle Nerve; 2014 Nov; 50(5):830-4. PubMed ID: 25111654 [TBL] [Abstract][Full Text] [Related]
23. An Atypical Presentation of Upper Motor Neuron Predominant Juvenile Amyotrophic Lateral Sclerosis Associated with Sánchez-Tejerina D; Restrepo-Vera JL; Rovira-Moreno E; Codina-Sola M; Llauradó A; Sotoca J; Salvado M; Raguer N; García-Arumí E; Juntas-Morales R Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011394 [TBL] [Abstract][Full Text] [Related]
24. Evaluating the completeness of the national ALS registry, United States. Kaye WE; Wagner L; Wu R; Mehta P Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):112-117. PubMed ID: 29020837 [TBL] [Abstract][Full Text] [Related]
25. Case-control study of environmental toxins and risk of amyotrophic lateral sclerosis involving the national ALS registry. Talbott EO; Malek AM; Arena VC; Wu F; Steffes K; Sharma RK; Buchanich J; Rager JR; Bear T; Hoffman CA; Lacomis D; Donnelly C; Mauna J; Vena JE Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):533-542. PubMed ID: 38591179 [TBL] [Abstract][Full Text] [Related]
26. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Wagner L; Rechtman L; Jordan H; Ritsick M; Sanchez M; Sorenson E; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):128-34. PubMed ID: 26399278 [TBL] [Abstract][Full Text] [Related]
27. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model. Conde B; Winck JC; Azevedo LF Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082 [TBL] [Abstract][Full Text] [Related]
29. The National Registry of Veterans with amyotrophic lateral sclerosis. Allen KD; Kasarskis EJ; Bedlack RS; Rozear MP; Morgenlander JC; Sabet A; Sams L; Lindquist JH; Harrelson ML; Coffman CJ; Oddone EZ Neuroepidemiology; 2008; 30(3):180-90. PubMed ID: 18421218 [TBL] [Abstract][Full Text] [Related]
30. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015. Punjani R; Wagner L; Horton K; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):123-130. PubMed ID: 31795746 [TBL] [Abstract][Full Text] [Related]
31. A revision to the United States national ALS registry's algorithm to improve Case-Ascertainment. Mehta P; Raymond J; Han M; Punjani R; Larson T; Berry JD; Brooks BR; Oskarsson B; Goutman SA; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):230-236. PubMed ID: 36194072 [TBL] [Abstract][Full Text] [Related]
32. Recruitment of population-based controls for ALS cases from the National ALS Registry. Bear TM; Malek AM; Foulds A; Rager J; Deperrior SE; Vena JE; Larson TC; Mehta P; Horton DK; Talbott EO Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):395-400. PubMed ID: 33860698 [No Abstract] [Full Text] [Related]
33. The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. Wingo TS; Cutler DJ; Yarab N; Kelly CM; Glass JD PLoS One; 2011; 6(11):e27985. PubMed ID: 22132186 [TBL] [Abstract][Full Text] [Related]
35. Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Kacem I; Sghaier I; Bougatef S; Nasri A; Gargouri A; Ajroud-Driss S; Gouider R Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):131-139. PubMed ID: 31858811 [No Abstract] [Full Text] [Related]
36. Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia. Nagel G; Unal H; Rosenbohm A; Ludolph AC; Rothenbacher D; BMC Neurol; 2013 Feb; 13():22. PubMed ID: 23414001 [TBL] [Abstract][Full Text] [Related]
37. Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism. Mehta P; Raymond J; Han MK; Larson T; Berry JD; Paganoni S; Mitsumoto H; Bedlack RS; Horton DK J Med Internet Res; 2021 Dec; 23(12):e28021. PubMed ID: 34878988 [TBL] [Abstract][Full Text] [Related]
38. Clinical and Genetic Features of Patients with Juvenile Amyotrophic Lateral Sclerosis with Fused in Sarcoma (FUS) Mutation. Yu X; Zhao Z; Shen H; Bing Q; Li N; Hu J Med Sci Monit; 2018 Dec; 24():8750-8757. PubMed ID: 30507891 [TBL] [Abstract][Full Text] [Related]
39. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) #500a. Kasarkis EJ; Dominic K; Oddone EZ Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():129-32. PubMed ID: 15512895 [TBL] [Abstract][Full Text] [Related]
40. Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study. Tseng CC; Chang SJ; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Yen JH Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1231-1237. PubMed ID: 27723283 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]